Condition
Calcitonin
Total Trials
3
Recruiting
2
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07655804Phase 3RecruitingPrimary
Subcutaneous Calcitonin in Acute Herpes Zoster
NCT06330168Not ApplicableCompletedPrimary
Paravertebral Calcitonin in Thoracotomy
NCT05805683Not ApplicableRecruitingPrimary
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
Showing all 3 trials